Viewing data from:

ELIXOPHYLLIN

ANDA

THEOPHYLLINE | A083921 | FOREST LABORATORIES INC

1 strength0 unique patents0 unique exclusivities

Medicare Part D Spending

CMS annual spending data for Elixophyllin (2023)

Total Spending

$7K

Total Claims

Beneficiaries

—

Avg Cost/Unit

$0.18

Spending Trend

$165K(2019)→$98K(2020)→$51K(2021)→$21K(2022)→$7K(2023)

YoY Change:-71.1%

5yr CAGR:-29.2%

Source: CMS Medicare Part D Spending by Drug (2023). Shows gross drug cost under Part D.

API Supply Chain5 active DMFs19 inactive

4 active API suppliers hold Drug Master Files for this ingredient.

SIEGFRIED PHARMACHEMIKALIEN MINDEN GMBHTHEOPHYLLINE ANHYDROUS

DMF 40971981

SHANDONG XINHUA PHARMACEUTICAL CO LTDTHEOPHYLLINE

DMF 46331982

SIEGFRIED PHARMACHEMIKALIEN MINDEN GMBHTHEOPHYLLINE HYDROUS

DMF 204552007

ALEMBIC PHARMACEUTICALS LTDTHEOPHYLLINE (ANHYDROUS) USP

DMF 353652020

DASAMI LAB PRIVATE LTDTHEOPHYLLINE ANHYDROUS USP

DMF 413192025

CONCORD LABORATORIES INCInactiveTHEOPHYLLINE CAPS., 250MG

DMF 27301976

CONCORD LABORATORIES INCInactiveTHEOPHYLLINE CAP

DMF 30401977

CORD LABORATORIES INC DIV SJ TUTAG AND COInactiveTHEOPHYLLINE CAPSULES, T.D.

DMF 31501978

KV PHARMACEUTICAL COInactiveTHEOPHYLLINE SUSTAINED RELEASE CAPSULES, 125 MG.

DMF 31621978

KV PHARMACEUTICAL COInactiveTHEOPHYLLINE S.R. CAPSULES, 250 MG.

DMF 31631978

KV PHARMACEUTICAL COInactiveTHEOPHYLLINE S.R. CAPSULES 125MG

DMF 32471978

CONCORD LABORATORIES INCInactiveTHEOPHYLLINE S.R. CAPS 300MG

DMF 36581979

KV PHARMACEUTICAL COInactiveTHEOPHYLLINE SR62.5MG MNFG IN ST.LOUIS,MO FOR SCHERING,KENILWORTH N.J.

DMF 37071980

ELAN CORP PLCInactiveTHEOPHYLLINE PHARMAZOME TM POWDER

DMF 61841986

ELAN CORP PLCInactiveTHEOPHYLLINE CONTROLLED RELEASE BEADS

DMF 63271986

ALTANA LOMBERG CHEMISCHE FABRIKInactiveTHEOPHYLLINE SUSTAINED RELEASE CAPSULES (BY-158)

DMF 68181987

ELAN PHARM RES CORPInactiveTHEOPHYLLINE CONTROLLED RELEASE BEADS

DMF 69921987

BOEHRINGER INGELHEIM PHARMA KGInactiveTHEOPHYLLINE MONOHYDRATE

DMF 73011988

ROHM PHARMA GMBHInactiveTHEOPHYLLINE R 85 D/02

DMF 73541988

DAN DONG PHARMACEUTICALSInactiveTHEOPHYLLINE

DMF 73871988

WEST GRAND CORPInactiveTHEOPHYLLINE

DMF 93871991

SHANGHAI WANDAI PHARMACEUTICAL CO LTDInactiveTHEOPHYLLINE (ANHYDROUS)

DMF 96851992

CSPC INNOVATION PHARM CO LTDInactiveTHEOPHYLLINE

DMF 224812009

HAINAN POLY PHARMACEUTICAL CO LTDInactiveTHEOPHYLLINE EXTENDED RELEASE CAPSULES

DMF 232442009

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — 200MG

0 patents0 exclusivities▴

CAPSULE;ORAL | Approved: Jul 31, 1984

No patent or exclusivity listings for this strength.